Charlie Swanton

Charlie Swanton is a Royal Society Napier Professor of Cancer and consultant thoracic oncologist at UCL Hospitals. He also serves as Chief Clinician at Cancer Research UK (CRUK) as well as group Leader of the Cancer Evolution and Genome Instability laboratory at CRUK and the Francis Crick Institute. He is a world leader in the understanding of genomic diversity within cancers (intratumour heterogeneity) and molecular mechanisms driving cancer branched evolution. He has published over 130 papers and is the recipient of a number of awards in recognition of his research. He is the co-director of the CRUK Lung Cancer Centre of Excellence and an appointed Fellow of the European Academy of Cancer Sciences (2014) and a Fellow of the Academy of Medical Sciences (2015), and Royal Society (2018). He is chief investigator of the UK cancer evolution program TRACERx. He has unparalleled experience in cell biology, bioinformatics and the development of a sequencing pipeline for the prediction and annotation of neoantigens. Charlie holds an MB BS and first class honours degree in Cell Biology and Immunology from UCL medical schools and PhD from the Imperial Cancer Research Fund.